Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Multicentre Double Blind Placebo Controlled Parallel Group Dose Ranging Study of ATL-962 to Assess Weight Loss, Safety and Tolerability in Obese Patients With Type II Diabetes Being Treated With Metformin, in Comparison With Orlistat

Projekt: Typer af projekter

Vis graf over relationer
StatusAfsluttet
Periode01/12/200431/10/2005
URLhttp://clinicaltrials.gov/ct/show/NCT00156897?order=38
Forskningsprogram<ingen navn>

ID: 32557220